stage III lymphoepithelioma of the nasopharynx
Showing 1 - 25 of >10,000
Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma
Completed
- Stage II Lymphoepithelioma of the Nasopharynx
- +5 more
- docetaxel
- +5 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 10, 2021
Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)
Recruiting
- Head and Neck Cancer
- biologic sample preservation procedure
- medical chart review
-
Nashville, Tennessee
- +3 more
Oct 28, 2022
Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)
Active, not recruiting
- Head and Neck Cancer
- carboplatin,
- +4 more
-
Singapore, SingaporeNational Cancer Centre - Singapore
Sep 27, 2022
Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2022
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Anorexia, Cachexia, Head Neck Cancer Trial in Winston-Salem (megestrol acetate, quality-of-life assessment)
Completed
- Anorexia
- +3 more
- megestrol acetate
- quality-of-life assessment
-
Winston-Salem, North CarolinaComprehensive Cancer Center at Wake Forest University
Sep 7, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- erlotinib hydrochloride
- +10 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)
Completed
- Head and Neck Cancer
- +3 more
- sargramostim
- oral salt and soda mouthwash
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 9, 2021
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Colorectal Cancer Trial in Taipei (Colectomy with NOSE procedure)
Recruiting
- Colorectal Cancer
- Colectomy with NOSE procedure
-
Taipei, TaiwanNational Taiwan University Hospital
Jul 23, 2023
Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Older People
- Short course radiotherapy
- +3 more
-
Edegem, Antwerpen, Belgium
- +12 more
Sep 18, 2023
Nasopharyngeal Carcinoma Trial in Hong Kong (Trans-oral magnifying endoscopy with NBI)
Recruiting
- Nasopharyngeal Carcinoma
- Trans-oral magnifying endoscopy with NBI
-
Hong Kong, Hong KongPrince of Wales Hospital
Aug 15, 2022
Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of
Recruiting
- Resectable Melanoma
- +2 more
- BCD-217
- +3 more
-
Lesnoy, Belarus
- +35 more
Feb 21, 2023
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Nivolumab in Treatment of Early Stage Esophageal or
Not yet recruiting
- Esophageal Carcinoma
- Gastroesophageal Junction Carcinoma
-
Louisville, Kentucky
- +2 more
Mar 21, 2023
Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T
Not yet recruiting
- Recurrent Glioblastoma
- Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
- (no location specified)
Apr 4, 2023
Intraoral Measurement of Pressure in Preterm Infants
Active, not recruiting
- Preterm Infants
- non-invasive ventilation
-
Göttingen, GermanyUniversity Medicine Göttingen
Nov 2, 2022
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Head Neck Cancer, Lung Cancer, Ovarian Cancer Trial in Vancouver, Hamilton, Toronto (cisplatin, lurtotecan liposome)
Completed
- Head and Neck Cancer
- +3 more
- cisplatin
- lurtotecan liposome
-
Vancouver, British Columbia, Canada
- +2 more
Apr 2, 2020
Ovarian Cancer Trial in Goyang (Cisplatin)
Not yet recruiting
- Ovarian Cancer
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center
Apr 24, 2023
Circulating Tumor Cells for Treatment Response of Lung Cancer
Recruiting
- Lung Neoplasm
- Lung Tumor Resection
-
San Antonio, TexasUT Health San Antonio, M.D. Anderson Cancer Center
Jan 23, 2023
Breast Cancer Female Trial (Pyrotinib and Trastuzumab)
Not yet recruiting
- Breast Cancer Female
- Pyrotinib and Trastuzumab
- (no location specified)
Sep 11, 2023